NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.
Week of November 11
CardioDx Inc. – Palo Alto, Calif., 5 million shares, priced $14 to $16, managed by BofA Merrill Lynch and Jefferies. Proposed Nasdaq symbol CDX. Business: Sells diagnostic tests for cardiovascular diseases.
Celladon Corp. – San Diego, Calif., 5 million shares, priced $14 to $16, managed by J.P. Morgan and Barclays. Proposed Nasdaq symbol CLDN. Business: Developing novel therapies for the treatment of heart disease.
Chegg Inc. – Santa Clara, Calif., 15 million shares, priced $10 to $12, managed by J.P. Morgan and BofA Merrill Lynch. Proposed NYSE symbol CHGG. Business: Leading online textbook rental and educational resource platform company.
Dynagas LNG Partners LP – Glyfada, Greece, 12.5 million common units, priced $19 to $21, managed by Credit Suisse, BofA Merrill Lynch, and Morgan Stanley. Proposed Nasdaq symbol DLNG. Business: Limited partnership focused on owning and operating LNG carriers.
Extended Stay America Inc. – Charlotte, N.C., 28.3 million shares, priced $18 to $21, managed by Deutsche Bank, Goldman Sachs, and J.P. Morgan. Proposed NYSE symbol STAY. Business: Largest owner and operator of company-branded hotels in North America.
Houghton Mifflin Harcourt Co. – Boston, 18.3 million shares, priced $14 to $16, managed by Goldman Sachs, Morgan Stanley, and Citigroup. Proposed Nasdaq symbol HMHC. Business: Leading global publisher of educational content, primarily K-12.
Relypsa Inc. – Redwood City, Calif., 6.9 million shares, priced $16 to $19, managed by Morgan Stanley and BofA Merrill Lynch. Proposed Nasdaq symbol RLYP. Business: Developing treatments for renal, cardiovascular and metabolic diseases.
Tandem Diabetes Care Inc. – San Diego, Calif., 7.1 million shares, priced $13 to $15, managed by BofA Merrill Lynch and Deutsche Bank. Proposed Nasdaq symbol TNDM. Business: Manufactures a next-generation insulin pump for diabetics.
Xencor Inc. – Monrovia, Calif., 5 million shares, priced $14 to $16, managed by Credit Suisse and Leerink Swann. Proposed Nasdaq symbol XNCR. Business: Biotech developing treatments for severe autoimmune and allergic diseases and cancer.
Zulily Inc. – Seattle, 11.5 million shares, priced $16 to $18, managed by Goldman Sachs, BofA merrill Lynch, and Citigroup. Proposed Nasdaq symbol ZU. Business: Flash sales site offering deals on children’s apparel and other products for moms.